CBIO vs XOMA
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 23, 2026
CBIO
XOMA
Investment Advisor Scores
XOMA
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CBIO | XOMA | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 0 | 21.4592 | Tie |
| PEG Ratio | 0 | -0.42 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 0.0% | -22.6% | CBIO |
| Earnings Growth | 0.0% | 207.9% | XOMA |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 37.8/100 | 46.3/100 | XOMA |
| Profit Margin | 0.0% | 69.6% | XOMA |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | SELL | HOLD | XOMA |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CBIO
NeutralMixed signals - no dominant trend phase, RSI 36
XOMA
NeutralMixed signals - no dominant trend phase, RSI 35
Fundamentals Snapshot
| Metric | CBIO | XOMA |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -5.4 | -803.4 |
| Trailing P/E | — | 28.2 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | -0.2% |
| Gross Margin | 1.0% | 1.0% |
| Operating Margin | -14.3% | 0.0% |
| EPS | -0.14 | 1.57 |
| Dividend Yield | — | — |